Finance

Beta
Lists
038070:KOSDAQ
Seoulin Bioscience Co Ltd
â‚©5,120.00
+2.71%
(+135.00) 1D
Jun 12, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 038070...
Open
â‚©5,030
High
â‚©5,220
Low
â‚©5,030
Mkt. cap
47.62B
Avg. vol.
173.27K
Volume
0.00
Dividend
1.91%
Quarterly dividend
â‚©24
Ex-dividend date
Dec 29, 2025
P/E ratio
93.63
52-wk high
â‚©8,659
52-wk low
â‚©4,780
EPS
â‚©55
Shares outstanding
9.30M
No. of employees
104
Open
â‚©5,030
High
â‚©5,220
Low
â‚©5,030
Mkt. cap
47.62B
Avg. vol.
173.27K
Volume
0.00
Dividend
1.91%
Quarterly dividend
â‚©24
Ex-dividend date
Dec 29, 2025
P/E ratio
93.63
52-wk high
â‚©8,659
52-wk low
â‚©4,780
EPS
â‚©55
Shares outstanding
9.30M
No. of employees
104
News stories
From sources across the web
About Seoulin Bioscience Co Ltd
CEO-
Employees104
Founded1984
Headquarters-
SectorBiotechnology
Websiteseoulin.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
16.22B
22.87B
19.96B
19.53B
Cost of goods sold
13.14B
17.75B
15.42B
15.08B
Cost of revenue
13.14B
17.75B
15.42B
15.08B
Research and development expenses
206.86M
238.24M
151.88M
212.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.87B
3.46B
4.04B
3.58B
Operating expense
3.42B
4.34B
4.40B
4.28B
Total operating expenses
16.55B
22.09B
19.82B
19.35B
Operating income
-332.43M
784.70M
142.28M
174.55M
Other non operating income
351.31M
15.28M
533.61M
43.66M
EBT including unusual items
112.06M
776.92M
-391.36M
154.36M
EBT excluding unusual items
87.38M
753.24M
490.88M
147.40M
Income tax expense
179.90M
21.67M
12.84M
2.95M
Effective tax rate
160.54%
2.79%
-3.28%
1.91%
Other operating expenses
129.86M
145.64M
86.57M
143.51M
Net income
-56.23M
766.94M
-355.69M
163.16M
Net profit margin
-0.35%
3.35%
-1.78%
0.84%
Earnings per share
-
-
-
-
Interest and investment income
151.07M
220.26M
236.78M
229.38M
Interest expense
-54.99M
-280.56M
-295.65M
-340.19M
Net interest expenses
96.08M
-60.30M
-58.87M
-110.81M
Depreciation and amortization charges
244.73M
242.48M
247.26M
264.16M
EBITDA
-49.17M
1.06B
426.51M
474.74M
Gain or loss from assets sale
2.00K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer